Nuvation Bio, Inc. (NUVB)
6.76
-0.17
(-2.45%)
USD |
NYSE |
Aug 24, 16:00
6.76
0.00 (0.00%)
After-Hours: 20:00
Nuvation Bio 1 Year Total Returns (Daily) : 152.9% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 152.9% |
| August 20, 2026 | 152.0% |
| August 19, 2026 | 169.9% |
| August 18, 2026 | 140.0% |
| August 17, 2026 | 135.6% |
| August 14, 2026 | 125.4% |
| August 13, 2026 | 133.7% |
| August 12, 2026 | 176.7% |
| August 11, 2026 | 184.4% |
| August 10, 2026 | 187.0% |
| August 07, 2026 | 182.1% |
| August 06, 2026 | 160.0% |
| August 05, 2026 | 168.8% |
| August 04, 2026 | 178.8% |
| August 03, 2026 | 176.2% |
| July 31, 2026 | 168.2% |
| July 30, 2026 | 178.0% |
| July 29, 2026 | 167.9% |
| July 28, 2026 | 162.4% |
| July 27, 2026 | 166.4% |
| July 24, 2026 | 155.8% |
| July 23, 2026 | 153.5% |
| July 22, 2026 | 178.7% |
| July 21, 2026 | 173.6% |
| July 20, 2026 | 172.2% |
| Date | Value |
|---|---|
| July 17, 2026 | 158.9% |
| July 16, 2026 | 152.9% |
| July 15, 2026 | 177.0% |
| July 14, 2026 | 175.7% |
| July 13, 2026 | 162.3% |
| July 10, 2026 | 151.5% |
| July 09, 2026 | 157.8% |
| July 08, 2026 | 186.3% |
| July 07, 2026 | 172.6% |
| July 06, 2026 | 167.9% |
| July 02, 2026 | 178.0% |
| July 01, 2026 | 179.4% |
| June 30, 2026 | 191.3% |
| June 29, 2026 | 190.7% |
| June 26, 2026 | 186.8% |
| June 25, 2026 | 209.0% |
| June 24, 2026 | 215.1% |
| June 23, 2026 | 197.5% |
| June 22, 2026 | 192.4% |
| June 18, 2026 | 210.6% |
| June 17, 2026 | 211.7% |
| June 16, 2026 | 175.3% |
| June 15, 2026 | 197.1% |
| June 12, 2026 | 171.8% |
| June 11, 2026 | 116.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Bristol Myers Squibb Co. | 44.96% |
| Johnson & Johnson | 54.80% |
| Eli Lilly & Co. | 77.98% |
| Pfizer Inc. | 16.73% |
| EyePoint, Inc. | -54.14% |